by Dan Roberts As reported in the Aug. 28, 2008 online edition of the New England Journal of Medicine, researchers have found a genetic link associated with dry AMD. That’s the good news. The bad news is that siRNA drug therapy may increase the risk for dry AMD in patients who have that genetic variant. [Read More]
News
Cone-Rod Dystrophy
by Dan Roberts (Updated February 21, 2016) Cone-Rod Dystrophy (CRD) is an inherited progressive disease that causes deterioration of the cone and rod photoreceptor cells and often results in blindness. It can be found as an autosomal dominant trait, but it is usually acquired as autosomal recessive. Symptoms of CRD are seen as decreased visual [Read More]
Lutein And Zeaxanthin May Offer Protection Against MD
by Dan Roberts 1995 (Updated July 2008) Progress is being made in the study of both lutein and zeaxanthin as potentially effective nutritional supplements for macular degeneration patients. According to a 1995 study, increasing the consumption of dark green, leafy vegetables appears to offer some protection against macular degeneration. Because nutritional factors may play a [Read More]
Summary of Research and Developments in Macular Degeneration: 2007-2008
Compiled and edited by Dan Roberts JUNE 2007 Omega-3 Proving to be Beneficial on Several Fronts Recent studies have shown that Omega-3 fatty acids and fish consumption may reduce the risks of age-related macular degeneration (AMD), Alzheimer’s disease, inflammation and depression. The Age-Related Eye Disease Study (AREDS) Research Group showed that dietary total Omega-3 and [Read More]
The Macular Disease Patient Charter
The Macular Disease Patient Charter, a bill of rights for people with macular disease, was developed and endorsed by AMD Alliance International in May 2008. The charter is a tool designed to outline the rights of people living with macular disease. It encourages them to seek the high quality of care they deserve through a [Read More]